IRIS
Bezzio, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.242
AS - Asia 1.382
EU - Europa 411
SA - Sud America 234
Continente sconosciuto - Info sul continente non disponibili 135
AF - Africa 33
OC - Oceania 2
Totale 4.439
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.139
SG - Singapore 799
CN - Cina 267
IT - Italia 197
BR - Brasile 185
VN - Vietnam 124
HK - Hong Kong 58
CA - Canada 52
DE - Germania 36
FR - Francia 34
IN - India 33
GB - Regno Unito 28
BD - Bangladesh 24
MX - Messico 22
FI - Finlandia 16
IE - Irlanda 15
AR - Argentina 14
NL - Olanda 14
RU - Federazione Russa 13
BE - Belgio 12
EC - Ecuador 12
ES - Italia 9
ZA - Sudafrica 9
AE - Emirati Arabi Uniti 7
JM - Giamaica 7
JP - Giappone 7
PK - Pakistan 7
AT - Austria 6
CO - Colombia 6
LT - Lituania 6
TR - Turchia 6
CR - Costa Rica 5
HN - Honduras 5
IL - Israele 5
IQ - Iraq 5
JO - Giordania 5
NP - Nepal 5
PE - Perù 5
PL - Polonia 5
TN - Tunisia 5
ID - Indonesia 4
MA - Marocco 4
NG - Nigeria 4
PY - Paraguay 4
SA - Arabia Saudita 4
CH - Svizzera 3
CL - Cile 3
CZ - Repubblica Ceca 3
EE - Estonia 3
IR - Iran 3
KE - Kenya 3
LV - Lettonia 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
CI - Costa d'Avorio 2
EG - Egitto 2
GT - Guatemala 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MY - Malesia 2
SE - Svezia 2
TW - Taiwan 2
UY - Uruguay 2
VE - Venezuela 2
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GR - Grecia 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
LU - Lussemburgo 1
ML - Mali 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
TV - Tuvalu 1
ZM - Zambia 1
Totale 4.304
Salva come PNG Salva come JPEG
Città #
Singapore 341
San Jose 276
Ashburn 224
Council Bluffs 143
The Dalles 108
Santa Clara 82
Milan 75
Beijing 72
Shanghai 67
Chandler 57
Dallas 56
Los Angeles 55
Hong Kong 53
Phoenix 41
Ho Chi Minh City 40
New York 37
Rome 33
Hanoi 30
Buffalo 28
Boardman 23
Princeton 18
Helsinki 15
Mexico City 15
Montreal 15
Brooklyn 14
Dublin 14
São Paulo 14
Chicago 11
Seattle 11
Lawrence 10
London 10
Secaucus 10
Atlanta 9
Charlotte 9
Figino 9
Orem 9
Wilmington 9
Amsterdam 8
Chennai 8
Denver 8
Düsseldorf 8
Houston 8
Las Vegas 8
Da Nang 7
Frankfurt am Main 7
San Francisco 7
Toronto 7
Lokeren 6
Long Beach 6
North Bergen 6
Philadelphia 6
Quito 6
Amman 5
Bakersfield 5
Birmingham 5
Boston 5
Jacksonville 5
Miami 5
Milwaukee 5
Paris 5
Queens 5
Rio de Janeiro 5
San Mateo 5
Tokyo 5
Albany 4
Benin City 4
Cleveland 4
Curitiba 4
Detroit 4
Dubai 4
Hamilton 4
Johannesburg 4
Louisville 4
Mumbai 4
Munich 4
Naples 4
Oakland 4
Orlando 4
Pittsburgh 4
Porto Alegre 4
Portsmouth 4
Raleigh 4
The Bronx 4
Warsaw 4
Washington 4
Alabaster 3
Anaheim 3
Antwerp 3
Belo Horizonte 3
Bossier City 3
Brasília 3
Brussels 3
Chandigarh 3
Cincinnati 3
Columbus 3
Concord 3
Davenport 3
Denton 3
Dhaka 3
Fort Lauderdale 3
Totale 2.338
Salva come PNG Salva come JPEG
Nome #
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 106
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 95
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors 94
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 80
The learning curve for using intestinal ultrasonography 78
Dietary Fiber in Inflammatory Bowel Disease: Are We Ready to Change the Paradigm? 77
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 73
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study 72
Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medication 71
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 69
Artificial intelligence in gastrointestinal endoscopy for inflammatory bowel disease: a systematic review and new horizons 67
Efficacy of a novel self-assembling peptide hemostatic gel as rescue therapy for refractory acute gastrointestinal bleeding 67
Prevalence and Clinical Impact of Immune-Mediated Inflammatory Diseases in Patients with Inflammatory Bowel Disease: Results from a Large Retrospective Observational Study 65
Efficacy and Safety of Adalimumab Biosimilar GP2017 in Patients with Inflammatory Bowel Disease 65
Neuroendocrine tumors in patients with inflammatory bowel disease: a case series 63
Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study 62
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease 60
Reporting of Magnetic Resonance Enterography in Inflammatory Bowel Disease: Results of an Italian Survey 59
The Impact of Ustekinumab Biosimilar on Therapeutic Strategies in Crohn's Disease: A Paradigm Shift? 59
Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections 58
Ophthalmological Manifestations in Inflammatory Bowel Diseases: Keep an Eye on It 58
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 57
Eosinophils, Eosinophilic Gastrointestinal Diseases, and Inflammatory Bowel Disease: A Critical Review 56
Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease – A comprehensive narrative review 56
Nutritional care at centres managing patients with inflammatory bowel disease: A nationwide survey in Italy 55
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus 55
Hold the Foam : Why Topical Budesonide Remains Relevant for IBD Therapy 55
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy 54
Ultrasonography Tight Control and Monitoring in Crohn’s Disease During Different Biological Therapies: A Multicenter Study 54
Impact of histologic disease activity on long-term outcomes in patients with ileal pouch-anal anastomosis for ulcerative colitis 54
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study 54
Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease 54
Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease 53
Planning phase two for endoscopic units in Northern Italy after the COVID-19 lockdown: An exit strategy with a lot of critical issues and a few opportunities 52
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 52
Clinical Characteristics of COVID-19 Patients With Gastrointestinal Symptoms in Northern Italy: A Single-Center Cohort Study 51
Prevalence, Risk Factors and Association with Clinical Outcomes of Malnutrition and Sarcopenia in Inflammatory Bowel Disease: A Prospective Study 51
Unmet needs of Italian physicians managing patients with inflammatory bowel disease 50
Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care study 50
Efficacy, safety and tolerability, the imperfect triangle arising from the new low volume colon preparations 49
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study 49
Management of proctitis in ulcerative colitis and the place of biological therapies 48
Endoscopic ultrasound-guided gallbladder drainage in pancreatic cancer and cholangitis: A case report 47
Gastrointestinal ultrasound in inflammatory bowel disease: Seeing beyond limits 47
IBD Flare in the COVID-19 Pandemic:Therapy Discontinuation Is to Blame 46
Does ProCore fine needle biopsy really improve the clinical outcome of endoscopic ultrasound-guided sampling of pancreatic masses? 44
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey 44
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 44
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology 42
Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology–Surgery Team to Include an Infectious Disease Specialist 42
Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds 40
Management of Post-Operative Crohn’s Disease: Knowns and Unknowns 40
Improvement in appropriateness and diagnostic yield of fast-track endoscopy during the COVID-19 pandemic in Northern Italy 39
Ulcerative colitis: Not only gut 39
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy 38
Collecting and Analyzing IBD Clinical Data for Machine-Learning: Insights from an Italian Cohort 37
Inflammatory bowel disease in a colorectal cancer screening population: Diagnosis and follow-up 35
Psoriasis and inflammatory bowel disease: concomitant IMID or paradoxical therapeutic effect? A scoping review on anti-IL-12/23 and anti-IL-23 antibodies 35
Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study 33
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population 33
A multicenter study on bowel preparation in inflammatory bowel disease patients: comparison between 1L-PEG-ASC and 2L-PEG regimens in an outpatient setting 31
Proposal for returning to routine endoscopy during the COVID-19 pandemic: what is really feasible? 30
Upadacitinib in Patients With Difficult-to-Treat Crohn’s Disease 28
Drug Development in Inflammatory Bowel Diseases: What Is Next? 24
Building a Robust Investigator-Initiated Platform: The I-CARE Experience 24
Attitudes of physicians managing inflammatory bowel disease toward alterations of liver function tests: an Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) survey 24
Ustekinumab and Janus Kinase Inhibitors Outperform Vedolizumab as Second-line Therapy in Anti-tumor Necrosis Factor-experienced Patients With Ulcerative Colitis 23
Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis 23
Clinical phenotypes and therapeutic outcomes in enteropathic arthritis: a multivariate analysis from a retrospective cohort 22
Insights into the role of gastrointestinal ultrasound in ulcerative colitis 21
What’s new in IBD research? Refining the agenda: Outcomes, patient-centered care, and technology 21
Chemoprevention of colorectal cancer in ulcerative colitis: digging deep in current evidence 21
Upper Gastrointestinal Crohn’s Disease: Shedding Light on the Obscure L4 Classification Meaning 20
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study 20
Long-term outcome of inflammatory bowel diseases with cytomegalovirus colitis 19
Combining Advanced Targeted Therapy in Inflammatory Bowel Disease: Current Practice and Future Directions 18
Aspecific ileitis: Crohn’s disease or not Crohn’s disease? A prospective study 18
GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation 18
Sessile Serrated Lesions in Inflammatory Bowel Disease: Hidden Players in Colitis-Associated Colorectal Cancer? 18
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study 18
Learning Curve in Intestinal Ultrasound: Advancing from Basic Skills to Advanced Competencies–Insights from the IUS IG-IBD Master Program 17
Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations 17
The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study 17
Does inflammatory bowel disease play a role in cognitive decline? A systematic review 16
Cancer Risk in Patients Treated with the JAK Inhibitor Tofacitinib: Systematic Review and Meta-Analysis 16
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 16
Abdominal pain after minor trauma in a patient with Crohn's disease 15
New Technologies for IBD Endoscopy 15
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study 15
Continuous clinical remission with biologics in ulcerative colitis: the ‘AURORA’ comparison study 15
Prevalence, Characteristics, Management, and Outcomes of Difficult-to-Treat Inflammatory Bowel Disease 15
How comparative studies can inform treatment decisions for Crohn’s disease 15
The impact of symptoms, irritable bowel syndrome pattern and diagnostic investigations on the diagnostic delay of Crohn's disease: A prospective study 15
Revolutionizing Crohn's disease monitoring: The emerging role of intestinal ultrasound 14
Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel disease 14
Prevalence of Disease-Related Malnutrition and Micronutrients Deficit in Patients with Inflammatory Bowel Disease: A Multicentric Cross-Sectional Study by the GSMII (Inflammatory Bowel Disease Study Group) 13
Sustainable monitoring in inflammatory bowel disease: comparative carbon, energy, waste, and cost impact of intestinal ultrasound versus colonoscopy 13
Tolerability of Bowel Preparation and Colonoscopy in IBD Patients: Results From a Prospective, Single-Center, Case–Control Study 13
Ulcerative colitis: current pharmacotherapy and future directions 13
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection 13
Totale 4.070
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.778
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 0 0 3 0 0 0 1 1 0 4 1
2022/2023138 21 2 11 20 11 16 0 13 21 13 8 2
2023/2024184 3 11 23 6 2 8 8 4 0 39 34 46
2024/2025729 7 7 20 17 6 47 47 70 130 169 102 107
2025/20262.003 228 95 71 158 118 120 464 92 135 135 197 190
2026/20271.361 273 274 678 136 0 0 0 0 0 0 0 0
Totale 4.439